[Form 4] Iridex Corp Insider Trading Activity

Rhea-AI Filing Summary

Iridex Corp (IRIX) Form 4: The reporting person, Romeo R. Dizon (CFO), made a purchase of 625 shares of Iridex common stock on 08/29/2025 at a price of $1.37 per share. Following the transaction, Mr. Dizon beneficially owned 52,375 shares. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person.

Positive

• Purchase disclosed: Reporting person acquired 625 shares on 08/29/2025 at $1.37 per share
• Increased ownership: Beneficial ownership reported as 52,375 shares following the transaction
• Complete disclosure: Form 4 includes transaction date, price, quantity, and signature

Negative

• None.

Insights

Financial Analyst

TL;DR: Insider purchase of 625 shares at $1.37 is a routine disclosure with limited market impact given the holding size.

The filing shows a straightforward open-market purchase by the company's CFO increasing beneficial ownership to 52,375 shares. The transaction is fully disclosed with price and quantity; there are no derivative transactions or additional material terms reported. This is a routine Section 16 disclosure and, by itself, provides limited new information about company performance or prospects.

Corporate Governance Expert

TL;DR: Form 4 properly reports an officer purchase and appears compliant with Section 16 reporting requirements.

The document identifies the reporting person, relationship to the issuer (Chief Financial Officer), transaction date, transaction code (P for purchase), quantity, price, and resulting beneficial ownership. The form includes a signature executed by an attorney-in-fact. There are no indications of amendments, derivative holdings, or coordination with other filing persons in this filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dizon Romeo R

(Last) (First) (Middle)

1212 TERRA BELLA AVENUE

(Street)

MOUNTAIN VIEW CA 94043

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
IRIDEX CORP [ IRIX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/29/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/29/2025		P		625	A	$1.37	52,375	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Nilo De Castro, Attorney-in-fact for Romeo R. Dizon	08/29/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did IRIX insider Romeo R. Dizon report on Form 4?

The Form 4 reports a purchase of 625 shares of Iridex common stock on 08/29/2025 at $1.37 per share.

How many IRIX shares does Romeo R. Dizon beneficially own after the reported transaction?

Following the reported purchase, Mr. Dizon beneficially owned 52,375 shares of IRIDEX common stock.

What is Romeo R. Dizon's role at IRIDEX as stated in the Form 4?

The Form 4 lists Romeo R. Dizon as an Officer with the title Chief Financial Officer.

Was the Form 4 signed and by whom?

Yes. The Form 4 was signed on 08/29/2025 by Nilo De Castro, Attorney-in-fact for Romeo R. Dizon.

Did the filing report any derivative transactions or dispositions?

No. Table II (derivative securities) contains no reported transactions, and the reported transaction in Table I is a purchase (code P).